Vehling. Prävalenz a ff ektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse. Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis. Psychother Psych Med. 2012;249–58.

Dinkel A, Herschbach P. Fear of progression in cancer patients and survivors. Psycho- Oncology. In: Herschbach P, Dinkel A, editors. Psycho-oncology (recent results in cancer research 197). second. Berlin: Springer; 2014. pp. 11–29.

Hinz A, Mehnert A, Ernst J, Herschbach P, Schulte T. Fear of progression in patients 6 months after cancer rehabilitation—a validation study of the fear of progression questionnaire FoP-Q-12. Support Care Cancer. 2015;23(6):1579–87.

Article  PubMed  Google Scholar 

Berg P, Book K, Dinkel A, Henrich G, Marten-Mittag B, Mertens D, et al. Progredienzangst bei chronischen Erkrankungen. PPmP Psychother Psychosom Medizinische Psychol. 2011;61(1):32–7.

Article  Google Scholar 

Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978–86.

Article  PubMed  Google Scholar 

Butow P, Sharpe L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncol (United States). 2018;32(1):32–8.

Google Scholar 

Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, et al. Fear of progression in chronic diseases: psychometric properties of the fear of progression questionnaire. J Psychosom Res. 2005;58(6):505–11.

Article  PubMed  Google Scholar 

Goebel S, Mehdorn HM. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates. Support Care Cancer. 2019;27(9):3521–9.

Article  PubMed  Google Scholar 

Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571–87.

Article  PubMed  Google Scholar 

Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors - a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.

Article  CAS  PubMed  Google Scholar 

Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Progredienzangst bei brustkrebspatientinnen - Validierung der kurzform des Progredienzangstfragebogens PA-F-KF. Z Psychosom Med Psychother. 2006;52(3):274–88.

PubMed  Google Scholar 

Yang Y, Sun H, Liu T, Zhang J, Wang H, Liang W, et al. Factors associated with fear of progression in chinese cancer patients: sociodemographic, clinical and psychological variables. J Psychosom Res [Internet]. 2018;114(September):18–24. https://doi.org/10.1016/j.jpsychores.2018.09.003.

Article  PubMed  Google Scholar 

Clever K, Schepper F, Pletschko T, Herschbach P, Christiansen H, Martini J. Psychometric properties of the fear of progression questionnaire for parents of children with cancer (FoP-Q-SF/PR). J Psychosom Res [Internet]. 2018;107(January):7–13. https://doi.org/10.1016/j.jpsychores.2018.01.008.

Article  PubMed  Google Scholar 

Mahendran R, Liu J, Kuparasundram S, Griva K. Validation of the English and simplified Mandarin versions of the fear of progression questionnaire-short form in Chinese cancer survivors. BMC Psychol. 2020;8(1):4–10.

Article  Google Scholar 

Ma S, Yang X, Xiang S, Lu G, Gong W, Chen W. Psychometric validation of the fear of progression questionnaire-short form in acute pancreatitis patients. Heliyon [Internet]. 2023;9(8):e19060. https://doi.org/10.1016/j.heliyon.2023.e19060.

Article  CAS  PubMed  Google Scholar 

Silva S, Bártolo A, Santos IM, Paiva D, Monteiro S. Validation of the Portuguese version of the fear of progression questionnaire-short form (FoP-Q-SF) in Portuguese cancer survivors. Healthc. 2022;10(12):2466.

Article  Google Scholar 

Abd Hamid N, Hamdan NA, Azman N, Leong Bin Abdullah MFI. Validation of the Malay version of the cancer therapy satisfaction questionnaire among Malaysian cancer patients. Malays J Public Heal Med. 2021;21(1):274–85.

Article  Google Scholar 

Hasannezhad Reskati M, Hosseini S, Alizadeh-Navaei R, Khosravi SMB. Effectiveness of acceptance and commitment therapy management on self-differentiation and fear of disease progression in patients with breast cancer. J Babol Univ Med Sci. 2020;22(1):110–8.

Google Scholar 

Aghdam A, Rahmani A, Nejad Z, Ferguson C, Mohammadpoorasl A, Sanaat Z. Fear of cancer recurrence and its predictive factors among Iranian cancer patients. Indian J Palliat Care. 2014;20(2):128–33.

Article  PubMed  PubMed Central  Google Scholar 

Hair JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis (7th ed.). Pearson College division. London: Person; 2014.

Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S. The hospital anxiety and depression scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:1–5.

Article  Google Scholar 

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version. Support Care Cancer. 1999;7(6):400–6.

Article  CAS  PubMed  Google Scholar 

Sitzia J. How valid and reliable are patient satisfaction data? An analysis of 195 studies. Int J Qual Heal Care. 1999;11(4):319–28.

Article  CAS  Google Scholar 

Lowshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563–75.

Article  Google Scholar 

Shi J, Mo X, Sun Z. Content validity index in scale development. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(2):152–5.

PubMed  Google Scholar 

Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer [Internet]. 2017;25(5):1401–7. https://doi.org/10.1007/s00520-016-3533-3.

Article  PubMed  Google Scholar 

Dankert A, Duran G, Engst-Hastreiter U, Keller M, Waadt S, Henrich G, et al. Progredienzangst bei patienten mit tumorerkrankungen, diabetes mellitus und entzündlich-rheumatischen erkrankungen. Rehabilitation. 2003;42(3):155–63.

Article  CAS  PubMed  Google Scholar 

Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, et al. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49(9):1217–22.

Article  CAS  PubMed  Google Scholar 

Pevzner. The relationship between illness uncertainty, anxiety, fear of progression, and quality of life in men with favorable risk prostate cancer undergoing active surveillance. Physiol Behav. 2017;176(3):139–48.

Google Scholar 

Niu L, Liang Y, Niu M. Factors influencing fear of cancer recurrence in patients with breast cancer: evidence from a survey in Yancheng, China. J Obstet Gynaecol Res. 2019;45(7):1319–27.

Article  PubMed  Google Scholar 

Howard EA. Tinsley SDB. Handbook of applied multivariate statistics and mathematical modeling. Academic Press; 2000. pp. 3–36

Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980;88(3):588–606.

Article  Google Scholar 

Zimmermann T, Herschbach P, Wessarges M, Heinrichs N. Fear of progression in partners of chronically ill patients. Behav Med. 2011;37(3):95–104.

Article  PubMed  Google Scholar 

Kwakkenbos L, Van Den Hoogen FHJ, Custers J, Prins J, Vonk MC, Van Lankveld WGJM, et al. Validity of the fear of progression questionnaire-short form in patients with systemic sclerosis. Arthritis Care Res. 2012;64(6):930–4.

Article  Google Scholar 

Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 1993;11(3):327–36.

Article  CAS  PubMed  Google Scholar 

Hassani Alimolk F, McDonald FE, Asghari-Jafarabadi M, Ahmadi F, Zenoozian S, Lashkari M, Patterson P. A randomized clinical trial: efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression. Psycho-Oncology. 2024:33(4);e6339.